Stroke Trial, Recruiting NCT07552610 Sponsor: Xuanwu Hospital, Beijing Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07552610
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are showing signs of a stroke affecting the front part of the brain (anterior circulation)
  • A scan (CTA, MRA, or DSA) has confirmed a blockage in a major blood vessel in the front part of the brain (such as the internal carotid artery or middle cerebral artery)
  • You are having a procedure to remove the blood clot (mechanical thrombectomy)
  • You are between 18 and 80 years old (male or female)
  • Before this stroke, you were largely independent in daily life (little or no disability)
  • The time between when you were last known to be well and the clot-removal procedure is 24 hours or less — this includes strokes noticed upon waking up
  • Your stroke severity score on a standard medical scale (NIHSS) is 6 or higher when you arrive at the hospital
  • A brain scan score (ASPECTS) shows a result of 3 or higher, indicating some healthy brain tissue remains
  • You or your legal representative are able to give written consent to participate

Who may not be able to join:

  • You have blockages in both the front and back of the brain, or blockages on both sides of the front of the brain at the same time
  • A standard stroke severity score (NIHSS) could not be measured before you were sedated or put on a breathing machine
  • You had a seizure at the start of your stroke that prevented doctors from measuring your stroke severity score
  • Both of your pupils are enlarged and unresponsive (confirm with trial site)
  • You have a known allergy to the study drug (sivelestat sodium) or any of its ingredients
  • You have a severe allergy or medical reason that means you cannot receive the contrast dye used in scans
  • Your blood pressure is very high and cannot be brought down with medication (above 185/110 mmHg)
  • Your blood sugar level is either very low (below 50 mg/dL) or very high (above 400 mg/dL)
  • Your platelet count (cells that help blood clot) is too low
  • You have a bleeding disorder, a clotting factor deficiency, or you have been taking blood-thinning medication recently with certain lab values outside the acceptable range
  • You have severe kidney disease or are on dialysis
  • You are unlikely to be able to complete a 90-day follow-up (for example, if you have no fixed address or live overseas)
  • Your stroke is thought to be caused by blood vessel inflammation (vasculitis) or an infected clot
  • There is a suspicion that your symptoms may be caused by a tear in the main artery from your heart (aortic dissection)
  • You have a brain tumour (except a small, slow-growing type called a meningioma), active bleeding in the brain, or an abnormal tangle of blood vessels in the brain
  • Brain imaging shows significant swelling causing a shift in brain structures
  • There is evidence of a tear in the carotid artery that is restricting blood flow
  • You have a pre-existing neurological or psychiatric condition that could affect how doctors assess your condition
  • You are pregnant or breastfeeding
  • You have a diagnosed rheumatic or autoimmune disease and are taking long-term immune-suppressing or steroid medications
  • You are currently receiving chemotherapy or certain other medications that affect the immune system (confirm specific medications with trial site)
  • You are already taking part in another clinical trial that could affect the results of this study
  • The trial doctors believe, for any other reason, that joining the trial would not be safe or suitable for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xuanwu Hospital, Beijing
Registry
ClinicalTrials.gov
Start date
22 June 2026
Est. completion
31 May 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Rate of modified Rankin Scale (mRS) score of 0-2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov